Is there a relationship between the index of electrophysiological balance and newly diagnosed atrial fibrillation in ischemic stroke patients?
Cardiovascular Journal of Africa · 2025
DOI: 10.5830/cvja-2025-006 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cardiovascular Journal of Africa, 2025. Verfasst von Bayram Bağırtan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sancaktepe Sehit Professor Doctor Ilhan Varank Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Heart Rate, Electrocardiography, Ambulatory.
Themen: Schlaganfall
Abstract (Originalsprache)
OBJECTIVE: The objective of this study was to investigate the association between the index of electrophysiological balance (iCEB) and ischaemic stroke (IS) and newly diagnosed atrial fibrillation (AF). AF is an independent risk factor for stroke. Study design: This is an observational study. Place and duration of the study: The study was conducted at the institution where the authors are employed (Şehit Prof Dr Ilhan Varank Training and Research Hospital, Istanbul, between 1 October 2021 and 1 April 2022). METHODOLOGY: We included 452 patients in this study diagnosed with IS. The patients participating in the research were separated into two categories: patients with and without AF on rhythm holter. Both groups were balanced in point of clinical, demographic, and echocardiographic features. iCEB was described and evaluated as the proportion of QT to QRS (QT/QRS); and ciCEB (QTc/QRS). A p-value under 0.05 was noted as significant. RESULTS: The mean old of the participants in the AF group (n = 250) was 72.4 ± 9.5 years but the control group (n = 202) was 62.1 ± 12.6) years (p < 0.001). Both groups were similar in point of demographic and clinical features. CHA2DS2-VASc score (5.2 ± 1.5 vs 4.3 ± 1.3, p < 0.001), QT duration (412.3 ± 48.1 vs 404.5 ± 41.5 ms, p = 0.029), cQT duration (456.3 ± 35.4 vs 441.9 ± 33.2 ms, p = 0.017), iCEB (4.4 ± 0.7 vs 4.1 ± 0.6 ms, p = 0.007), ciCEB (4.9 ± 0.8 vs 4.6 ± 0.4 ms, p = 0.005) were higher in the AF group. Multivariable analyses confirmed that only age (OR:1.075, 95% CI [1.058-1.107], p < 0.001) and the iCEB (OR:1.781, 95% CI [1.128 - 2.812], p = 0.013) are potential independent risk factors for AF events with ischaemic stroke patients. CONCLUSION: The study concluded with the finding that iCEB and ciCEB values were elevated in patients who presented with IS and AF events detected on rhythm Holter. Concurrently, these patients exhibited higher CHA2DS2-VASc scores and advanced age. Furthermore, the iCEB parameter was found to be a valuable predictor of AF in patients with ischaemic stroke and normal sinus rhythm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Sancaktepe Sehit Professor Doctor Ilhan Varank Training and Research Hospital, Istanbul, Turkey.
- Department of Cardiology, University of Health Sciences Kosuyolu Training and Research Hospital,˙Istanbul, Turkey. Email: dr.songulusalp@hotmail.com.
Zitieren
APA
Bağırtan, B., Usalp, S., Demiröz, Ö., Bayraktar, A., Özdemir, B., & Karabay, K. Ö. (2025). Is there a relationship between the index of electrophysiological balance and newly diagnosed atrial fibrillation in ischemic stroke patients?. Cardiovascular Journal of Africa. https://doi.org/10.5830/cvja-2025-006
Vancouver
Bağırtan B, Usalp S, Demiröz Ö, Bayraktar A, Özdemir B, Karabay KÖ. Is there a relationship between the index of electrophysiological balance and newly diagnosed atrial fibrillation in ischemic stroke patients?. Cardiovascular Journal of Africa. 2025. doi:10.5830/cvja-2025-006
BibTeX
@article{Bartan2025,
author = {Bağırtan, Bayram and Usalp, Songül and Demiröz, Önder and Bayraktar, Ali and Özdemir, Behzat and Karabay, Kanber Öcal},
title = {Is there a relationship between the index of electrophysiological balance and newly diagnosed atrial fibrillation in ischemic stroke patients?},
journal = {Cardiovascular Journal of Africa},
year = {2025},
doi = {10.5830/cvja-2025-006}
}
EUVIMED